0001140361-18-043570.txt : 20181121
0001140361-18-043570.hdr.sgml : 20181121
20181121161752
ACCESSION NUMBER: 0001140361-18-043570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181119
FILED AS OF DATE: 20181121
DATE AS OF CHANGE: 20181121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DSM International B.V.
CENTRAL INDEX KEY: 0001706502
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34885
FILM NUMBER: 181198389
BUSINESS ADDRESS:
STREET 1: HET OVERLOON 1
CITY: HEERLEN
STATE: P7
ZIP: 6411 TE
BUSINESS PHONE: 31-455782870
MAIL ADDRESS:
STREET 1: HET OVERLOON 1
CITY: HEERLEN
STATE: P7
ZIP: 6411 TE
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Koninklijke DSM N.V.
CENTRAL INDEX KEY: 0001121615
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34885
FILM NUMBER: 181198390
BUSINESS ADDRESS:
STREET 1: HET OVERLOON 1 HEERLEN
STREET 2: PO BOX 6401 JH HEERLEN
CITY: NETHERLANDS
STATE: P7
ZIP: -
BUSINESS PHONE: 2122252142
MAIL ADDRESS:
STREET 1: HET OVERLOON 1 HEERLEN
STREET 2: PO BOX 6401 JH HEERLEN
CITY: NETHERLANDS
STATE: P7
ZIP: -
FORMER NAME:
FORMER CONFORMED NAME: DSM NV
DATE OF NAME CHANGE: 20000809
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYRIS, INC.
CENTRAL INDEX KEY: 0001365916
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 550856151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-0761
MAIL ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC
DATE OF NAME CHANGE: 20060613
4
1
form4.xml
FORM 4
X0306
4
2018-11-19
0001365916
AMYRIS, INC.
AMRS
0001706502
DSM International B.V.
HET OVERLOON 1
HEERLEN
P7
6411 TE
NETHERLANDS
true
true
0001121615
Koninklijke DSM N.V.
HET OVERLOON 1
HEERLEN
P7
6411 TE
NETHERLANDS
true
true
Common Stock
2018-11-19
4
A
0
1643991
A
10328951
I
See footnote
Common Stock
2018-11-19
4
X
0
964837
0.0015
A
11293788
I
See footnote
Common Stock
2018-11-19
4
X
0
1713565
0.0001
A
13007353
I
See footnote
Warrants (right to buy)
0.0015
2018-11-19
4
J
0
964837
0
A
2018-11-19
2022-07-10
Common Stock
964837
964837
I
See footnote
Warrants (right to buy)
0.0001
2018-11-19
4
J
0
1713565
0
A
2018-11-19
2023-05-23
Common Stock
1713565
1713565
I
See footnote
Warrants (right to buy)
0.0015
2018-11-19
4
X
0
964837
0
D
2018-11-19
2022-07-10
Common Stock
964837
0
I
See footnote
Warrants (right to buy)
0.0001
2018-11-19
4
X
0
1713565
0
D
2018-11-19
2023-05-23
Common Stock
1713565
0
I
See footnote
In consideration of certain agreements of affiliates of the Reporting Persons set forth in a commercial agreement entered into with the Issuer on November 19, 2018, the Issuer's board of directors approved the issuance of the shares reported herein.
The securities reported herein are held of record by DSM International B.V., which is a wholly owned subsidiary of Koninklijke DSM N.V. Accordingly, Koninklijke DSM N.V. may be deemed to share beneficial ownership of the securities held of record by DSM International B.V. Koninklijke DSM N.V. is a publicly traded company with securities listed on the Amsterdam Stock Exchange.
In connection with an investment in the Issuer by a third party on August 3, 2017, as agreed by DSM International B.V. and the Issuer on November 19, 2018, the anti-dilution provisions of the Warrants were triggered, resulting in the Warrants becoming exercisable for 964,837 shares of Common Stock at an exercise price of $0.0015 per share, which Warrants were exercised by the Reporting Persons on November 19, 2018.
In connection with amendments to existing securities of the Issuer held by a third party on August 17, 2018, as agreed by DSM International B.V. and the Issuer on November 19, 2018, the anti-dilution provisions of the Warrants were triggered, resulting in the Warrants becoming exercisable for 1,713,565 shares of Common Stock at an exercise price of $0.0001 per share, which Warrants were exercised by the Reporting Persons on November 19, 2018.
DSM International B.V.
By: /s/ Hugh Welsh, President, DSM North America
2018-11-21
Koninklijke DSM N.V.
By: /s/ Hugh Welsh, President, DSM North America
2018-11-21